International Journal of Retina and Vitreous
Scope & Guideline
Transforming ophthalmology with open-access discoveries.
Introduction
Aims and Scopes
- Research on Retinal Diseases:
The journal consistently publishes studies on various retinal conditions, including age-related macular degeneration, diabetic retinopathy, and retinal detachment, emphasizing both clinical and experimental research. - Innovative Surgical Techniques:
A core focus of the journal is the exploration of new surgical methods and technologies in vitreoretinal surgery, including vitrectomy techniques and the use of advanced imaging modalities. - Artificial Intelligence Applications:
The journal highlights the integration of artificial intelligence and machine learning in ophthalmology, particularly in diagnostics and treatment planning for retinal diseases. - Systematic Reviews and Meta-Analyses:
Regular publications feature systematic reviews and meta-analyses that synthesize existing research, providing comprehensive insights and evidence-based recommendations for clinical practice. - Clinical Outcomes and Long-Term Follow-Up Studies:
Research assessing the long-term outcomes of various treatment modalities and interventions for retinal conditions is a key area of focus, contributing to improved patient management.
Trending and Emerging
- Artificial Intelligence and Machine Learning:
There is a marked increase in research exploring the applications of AI and machine learning in diagnosing and managing retinal diseases, indicating a trend towards leveraging technology for enhanced patient care. - Advanced Imaging Techniques:
The journal is witnessing a surge in studies utilizing novel imaging technologies, such as optical coherence tomography (OCT) and OCT angiography, to provide deeper insights into retinal conditions and treatment efficacy. - Personalized and Precision Medicine:
Emerging themes of personalized treatment approaches and precision medicine in managing retinal diseases are becoming more prevalent, reflecting a shift towards tailoring therapies based on individual patient characteristics. - Combination Therapies:
Research focusing on combination therapies, particularly in the treatment of complex conditions like diabetic macular edema and neovascular age-related macular degeneration, is trending as clinicians seek to enhance treatment outcomes. - Telemedicine and Remote Monitoring:
The rise of telemedicine and remote monitoring tools for retinal disease management is increasingly featured, emphasizing the need for accessible care solutions in the current healthcare landscape.
Declining or Waning
- Traditional Pharmacological Treatments:
Research centered on conventional pharmacological treatments for retinal diseases, such as corticosteroids and older anti-VEGF therapies, has decreased as newer agents and combination therapies gain attention. - Basic Science and Animal Studies:
There is a noticeable decline in purely basic science research and animal studies, as the journal increasingly prioritizes clinical applications and translational research that directly impacts patient care. - Epidemiological Studies:
The frequency of epidemiological studies related to retinal conditions appears to be waning, likely due to a growing emphasis on clinical trials and therapeutic interventions. - Historical Perspectives:
Papers focusing on historical reviews or perspectives of retinal surgery and treatment practices are less common, as the journal shifts towards contemporary issues and future directions in the field. - Surgical Complications Reporting:
While surgical outcomes remain a critical area, the specific reporting on complications and their management has seen a reduction, possibly due to a focus on positive outcomes and advancements in techniques.
Similar Journals
Eye and Vision
Advancing the frontiers of ophthalmology and visual sciences.Eye and Vision, published by BMC, is a leading open-access journal dedicated to the dynamic field of ophthalmology and visual sciences. With its ISSN 2326-0246 and E-ISSN 2326-0254, the journal has established itself as a premier platform for innovative research and clinical studies, achieving impressive rankings in 2023 as Q1 in both Health Professions (Miscellaneous) and Ophthalmology categories. The journal's commitment to accessible knowledge since its transition to open access in 2015 enhances its global reach, allowing researchers, clinicians, and students to share and access top-tier studies and advancements in the field. Located in the United Kingdom and delivering influential insights from 2014 through to 2024, Eye and Vision holds significant relevance, with a Scopus ranking placing it in the 99th percentile for Health Professions and the 93rd percentile for Ophthalmology, making it an essential resource for those looking to stay at the forefront of eye research and vision science.
CURRENT EYE RESEARCH
Transforming Insights into Eye Care SolutionsCURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.
SURVEY OF OPHTHALMOLOGY
Shaping the Future of Eye Care ResearchSURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.
Journal of VitreoRetinal Diseases
Transforming knowledge into practice for retinal care.Journal of VitreoRetinal Diseases is a leading publication in the field of ophthalmology, specifically focusing on the complex landscape of vitreo-retinal conditions. Released by SAGE Publications Inc, this journal plays a crucial role in advancing the understanding and treatment of retinal diseases through high-quality, peer-reviewed research. With an ISSN of 2474-1264 and an E-ISSN of 2474-1272, the journal has gained recognition since its inception in 2017, currently ranking in the Q3 category of ophthalmology based on its Scopus metrics. Positioned within the 31st percentile among its peers, the journal provides a platform for the dissemination of innovative findings and clinical practices. Although it operates under a traditional access model, the significance of its contributions is profound, making it an essential resource for researchers, healthcare professionals, and students dedicated to improving patient outcomes in retinal health.
Seminars in Ophthalmology
Empowering Practitioners with Cutting-Edge FindingsSeminars in Ophthalmology is a prestigious journal published by Taylor & Francis Inc, dedicated to advancing knowledge in the field of ophthalmology and related medical areas. Established in 1986, this journal has consistently provided a platform for high-quality research and insights, supporting the community with its impactful publications. With an impressive ranking of #55 out of 137 in the Ophthalmology category, the journal currently holds a Q2 quartile in both ophthalmology and miscellaneous medicine as of 2023, reflecting its significant contribution to the discipline. Researchers and practitioners can access a wealth of information covering a comprehensive range of topics, bolstering both clinical practice and academic inquiry. While not an open-access publication, Seminars in Ophthalmology remains a crucial resource for advancing ophthalmic research, fostering collaboration, and disseminating valuable findings in a rapidly evolving specialty.
EUROPEAN JOURNAL OF OPHTHALMOLOGY
Empowering Clinicians with Groundbreaking FindingsThe EUROPEAN JOURNAL OF OPHTHALMOLOGY, published by SAGE PUBLICATIONS LTD, is a leading international journal in the field of ophthalmology, dedicated to advancing the understanding and treatment of ocular diseases and disorders. With an ISSN of 1120-6721 and an E-ISSN of 1724-6016, the journal aims to provide a platform for innovative research, critical reviews, and comprehensive studies that span the diverse aspects of the discipline. As part of its commitment to disseminating high-quality research, the journal is indexed in Scopus, achieving an impressive rank of #47 out of 137 in the Medicine - Ophthalmology category, indicating its strong impact within the academic community. With a current impact factor that places it in the Q2 quartile for both Medicine (miscellaneous) and Ophthalmology as of 2023, it offers researchers and practitioners access to important findings and developments in eye health. The journal's converged years from 1991 to 2024 exemplify its longstanding commitment to the field, making it an essential resource for anyone looking to stay at the forefront of ophthalmological research.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Elevating Standards in Clinical Ophthalmic ResearchCLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.
EXPERIMENTAL EYE RESEARCH
Shaping the Future of Ophthalmology with Groundbreaking StudiesEXPERIMENTAL EYE RESEARCH, published by Academic Press Ltd - Elsevier Science Ltd, is a preeminent journal dedicated to advancing the fields of ophthalmology and neuroscience. With a history of insightful publications dating back to 1961, this journal serves as a critical platform for researchers, professionals, and students interested in the cellular and molecular mechanisms underlying visual processes. The journal boasts impressive rankings, including being placed in the top quartile (Q1) of both the Ophthalmology and Sensory Systems categories, and is recognized in the 2nd quartile (Q2) for Cellular and Molecular Neuroscience. With an impact factor reflecting its significant contribution to the field, EXPERIMENTAL EYE RESEARCH is a valuable resource that promotes the exchange of innovative research and ideas essential for understanding the complexities of eye function and vision-related disorders. Researchers looking to publish their findings or stay abreast of the latest studies will find this journal a vital component of their academic toolkit.
Expert Review of Ophthalmology
Pioneering Innovations in OphthalmologyExpert Review of Ophthalmology is a leading academic journal published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, specializing in the rapidly evolving field of ophthalmology. With its ISSN 1746-9899 and E-ISSN 1746-9902, this journal has been at the forefront of disseminating critical research and insightful reviews since its inception in 2006. Covering a broad spectrum of topics within ophthalmology, it plays a pivotal role in advancing knowledge and practice, especially given its prestigious standings in various quartile rankings, including Q1 in Public Health and Q2 in Immunology and Allergy for 2023. The journal aims to provide professionals, researchers, and students with comprehensive perspectives on contemporary challenges and innovations in ophthalmology. Generously supported by a robust peer-review process, the journal ensures that all published works meet high academic standards, thereby serving as a vital resource for anyone looking to stay informed about the latest developments in eye care and vision science. By bridging research and clinical application, Expert Review of Ophthalmology is essential for those aiming to contribute meaningfully to this critical field.
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
Exploring the frontiers of vision science and surgical excellence.ARQUIVOS BRASILEIROS DE OFTALMOLOGIA is a prominent peer-reviewed journal dedicated to the field of ophthalmology, published by CONSEL BRASIL OFTALMOLOGIA since its inception in 1945. With its commitment to disseminating high-quality research, the journal has transitioned to an Open Access model since 2001, ensuring that vital findings in ophthalmology are freely available to researchers, clinicians, and students alike. Located in São Paulo, Brazil, this esteemed publication occupies a significant position in the medical field, currently holding a Q3 ranking in both the miscellaneous medicine and ophthalmology categories. Although it maintains a legacy of fluctuating impact, recognized for its contribution to the academic community, ARQUIVOS BRASILEIROS DE OFTALMOLOGIA continues to attract a diverse international readership, making it a valuable resource for advancements in eye health, surgical techniques, and ocular research.